DFX Intelligence
Private Equity Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Transactions / A••••••••
H•••••• Capital Management Completes Strategic Investment in A••••••••
Growth investmentclosedannounced May 2, 2023closed May 2, 2023Fact
What happened
- Target
- A••••••••
- Platform
- not an add-on on record
- Control
- unknown
- Share acquired
- unknown
- Industry
- healthcare / infusion, medical, pharma
- Target location
- unknown
- Seller kind
- unknown
- Rollover
- unknown
Values, only where disclosed
- Enterprise value
- Not disclosed
- Purchase price
- Not disclosed
- Equity value
- Not disclosed
- Target revenue
- Not disclosed
- Target EBITDA
- Not disclosed
- Multiple
- Not disclosed
Parties and roles
8 named
Buy side
- “S•••••• H•••••••••, Managing Director at H••••••, added, “R••• and the entire A•••••••• team have done a remarkable job of building what we believe is a fantastic business that possesses significant growth potential.”
- ““We seek to back exceptional management teams in structurally attractive healthcare sectors that have sizeable market potential, excellent growth prospects, attractive innovation opportunities and manageable pricing trends and competition,” said A••••• G••••••, Co-Founder and Managing Partner of H••”
- “H•••••• Capital Management is a healthcare-focused private equity firm that seeks opportunities to create value in middle-market companies.”
Advisory side
- H•••••• • K•••••Legal adviserconfirmed“H•••••• • K••••• served as legal counsel for H•••••• Capital.”
- K•• G••••• L••Legal adviserconfirmed“K&L G•••• and K••••• L•• served as legal counsel for A•••••••• and Cantor Fitzgerald served as the Company’s exclusive financial advisor.”
- K••••• L••Legal adviserconfirmed“K&L G•••• and K••••• L•• served as legal counsel for A•••••••• and Cantor Fitzgerald served as the Company’s exclusive financial advisor.”
Side not stated
- “said R••• C••••••, Chief Executive Officer of A••••••••.”
- “H•••••• Capital Management, (“H••••••” or the “Firm”) a healthcare-focused private equity firm that specializes in partnering with middle-market companies to help scale their businesses and create value, today announced that it has completed a strategic investment in A••••••••, (the “Company”) a lea”
Evidence
“H•••••• Capital Management, (“H••••••” or the “Firm”) a healthcare-focused private equity firm that specializes in partnering with middle-market companies to help scale their businesses and create value, today announced that it has completed a strategic investment in A••••••••, (the “Company”) a leading provider of infusion and specialty pharmacy services across the country.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 16, 2026